A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

Project: Research project

Project Details

StatusFinished
Effective start/end date12/10/20 → 11/30/23

Funding

  • Roche Laboratories, Inc ( Award # ): $11,042.00